These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 21077951

  • 1. Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation.
    Moini M, Hoseini-Asl MK, Taghavi SA, Sagheb MM, Nikeghbalian S, Salahi H, Bahador A, Motazedian M, Jafari P, Malek-Hosseini SA.
    Clin Transplant; 2011; 25(4):638-45. PubMed ID: 21077951
    [Abstract] [Full Text] [Related]

  • 2. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA.
    Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
    [Abstract] [Full Text] [Related]

  • 3. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA.
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [Abstract] [Full Text] [Related]

  • 4. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
    Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG.
    Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386
    [Abstract] [Full Text] [Related]

  • 5. Impact of preoperative serum sodium concentration in living donor liver transplantation.
    Fukuhara T, Ikegami T, Morita K, Umeda K, Ueda S, Nagata S, Sugimachi K, Gion T, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y.
    J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
    [Abstract] [Full Text] [Related]

  • 6. Evidence-based incorporation of serum sodium concentration into MELD.
    Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G.
    Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
    [Abstract] [Full Text] [Related]

  • 7. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 8. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 9. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 10. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA.
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [Abstract] [Full Text] [Related]

  • 11. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC, Liver Transplantation Group.
    Clin Transplant; 2012 Apr; 26(4):E395-401. PubMed ID: 22882694
    [Abstract] [Full Text] [Related]

  • 12. Hyponatremia increases mortality in pediatric patients listed for liver transplantation.
    Carey RG, Bucuvalas JC, Balistreri WF, Nick TG, Ryckman FR, Yazigi N.
    Pediatr Transplant; 2010 Feb; 14(1):115-20. PubMed ID: 19254244
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for long-term mortality in a large cohort of patients wait-listed for liver transplantation in Brazil.
    Basto ST, Villela-Nogueira CA, Tura BR, Coelho HS, Ribeiro J, Fernandes ES, Schmal AF, Victor L, Luiz RR, Perez RM.
    Liver Transpl; 2011 Sep; 17(9):1013-20. PubMed ID: 21604358
    [Abstract] [Full Text] [Related]

  • 14. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M, Hernández Perera JC, Ramos Robaina L, Barroso Márquez L, González Rapado L, Cepero Valdés M, Hernández Rivero H, Abdo Cuza A, Valdés AR, Pérez Bernal J, Bernardos A.
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [Abstract] [Full Text] [Related]

  • 15. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P.
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [Abstract] [Full Text] [Related]

  • 16. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 17. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 18. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
    Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J.
    Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415
    [Abstract] [Full Text] [Related]

  • 19. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE, Darwish WM, Davies MG, Waldman DL.
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [Abstract] [Full Text] [Related]

  • 20. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.